BC
APLT

Birchview Capital’s Applied Therapeutics APLT Stock Holding History

Birchview Capital’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-225,000
Closed -$136K – 69
2025
Q3 		$136K Sell
225,000
-55,000
-20% -$25.9K 0.1% 65
2025
Q2 		$87.1K Buy
+280,000
New +$108K 0.09% 65

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Birchview Capital's APLT Position: Q4 2025 in Review

Birchview Capital sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 225,000 shares — an estimated $136K sold.

Birchview Capital first reported a position in APLT in Q2 2025 and held it in 2 quarters. The position peaked at $136K in Q3 2025. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

  • Birchview Capital reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Birchview Capital sold 225,000 Applied Therapeutics shares in Q4 2025, an estimated $136K.
  • Birchview Capital first reported a position in Applied Therapeutics in Q2 2025 and held it in 2 quarters.
  • Birchview Capital's Applied Therapeutics position peaked at $136K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Birchview Capital's 13F filing for Q4 2025, filed 13 Feb 2026.